EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 52023XC0327(02)
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2023/C 111/05
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2023/C 111/05
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (OJ L 396, 30.12.2006, p. 1.)) (Text with EEA relevance) 2023/C 111/05
C/2023/1771
OJ C 111, 27.3.2023, p. 5–6
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
- Date of document:
- 27/03/2023; Date of publication
- Author:
- European Commission, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs
- Form:
- Summary
- Additional information:
- EEA relevance
- Legal basis:
-
- 32006R1907 - A64P9 32006R1907 - ANXIV
- Link
- Link
- Link
- Select all documents mentioning this document
- Link
- EUROVOC descriptor:
- Subject matter:
- Directory code:
|
27.3.2023 |
EN |
Official Journal of the European Union |
C 111/5 |
Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1))
(Text with EEA relevance)
(2023/C 111/05)
Decision granting an authorisation
|
Reference of the decision (2) |
Date of decision |
Substance name |
Holder of the authorisation |
Authorisation number |
Authorised use |
Date of expiry of review period |
Reasons for the decision |
|
C(2023) 1771 |
20 March 2023 |
4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (‘4-tert-OPnEO’) EC No.-; CAS No.- 4-Nonylphenol, branched and linear, ethoxylated (4-NPnEO) EC No.-; CAS No.- |
Bio-Rad, 3 Boulevard Raymond Poincaré, 92430 Marnes-la-Coquette, France |
REACH/23/9/0 |
Industrial use of 4-tert-OPnEO for its non-ionic detergent properties in view of controlling reactions and chromatography support saturation required in the production of highly specific and sensitive in vitro immunoassays dedicated to the diagnosis of viral (HIV, HCV, Dengue) and parasitic infections Industrial use of 4-NPnEO for its non-ionic detergent properties in view of controlling reactions and chromatography support saturation required in the production of highly specific and sensitive in vitro immunoassays dedicated to the diagnosis of viral (HIV, HCV, Dengue) and parasitic infections Industrial use of 4-tert-OPnEO for its non-ionic detergent properties in the formulation of in vitro reagents dedicated to high-performance microbiological and immunological assays supported on microplates or magnetic particles Industrial use of 4-tert-OPnEO for its detergent properties used for extraction, viral inactivation and purification of biological material further formulated and /or coated on articles intended for IVD applications Industrial use of raw material containing 4-tert-OPnEO for protein stabilization for veterinary in vitro diagnostic application |
4 January 2033 |
In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socio-economic benefits outweigh the risk to human health and the environment from the use of the substance and there are no suitable alternative substances or technologies. |
|
REACH/23/9/1 |
4 January 2033 |
||||||
|
REACH/23/9/2 |
4 January 2033 |
||||||
|
REACH/23/9/3 |
4 January 2033 |
||||||
|
REACH/23/9/4 |
4 January 2028 |
(1) OJ L 396, 30.12.2006, p. 1.
(2) The decision is available on the European Commission website at: Authorisation (europa.eu).
